Table 2.
1st week (n = 4) | 2nd week (n = 11) | 3rd week (n = 13) | 4th week (n = 8) | |
---|---|---|---|---|
Clinical severity (%) | ||||
Moderate | 0 | 18% (2) | 15% (2) | 12.5% (1) |
Severe | 25% (1) | 18% (2) | 23% (3) | 25% (2) |
Critical | 75% (3) | 64% (7) | 62% (8) | 62.5% (5) |
Pleural line abnormalities | 100% (4) | 100% (11) | 100% (13) | 100% (8) |
B-lines | 100% (4) | 100% (11) | 100% (13) | 100% (8) |
Separated B-lines | 50% (2) | 46% (5) | 69% (9) | 75% (6) |
Confluent B-lines | 75% (3) | 91% (10) | 85% (11) | 75% (6) |
Compact B-lines | 25% (1) | 18% (2) | 15% (2) | 0 |
Bilateral involvement | 100% (4) | 100% (11) | 100% (13) | 87.5% (7) |
Anterior upper area | 100% (4) | 91% (10) | 85% (11) | 87.5% (7) |
Anterior lower area | 100% (4) | 91% (10) | 77% (10) | 75% (6) |
Lateral area | 100% (4) | 100% (11) | 100% (13) | 100% (8) |
Interscapular area | 100% (4) | 100% (11) | 100% (13) | 87.5% (7) |
Infrascapular area | 100% (4) | 100% (11) | 100% (13) | 100% (8) |
Consolidation | 50% (2) | 55% (6) | 77% (10) | 62.5% (5) |
Bilateral involvement | 25% (1) | 55% (6) | 36% (4) | 25% (2) |
Anterior upper area | 0 | 9% (1) | 0 | 0 |
Anterior lower area | 0 | 9% (1) | 8% (1) | 0 |
Lateral area | 0 | 18% (2) | 8% (1) | 0 |
Interscapular area | 50% (2) | 55% (6) | 54% (7) | 62.5% (5) |
Infrascapular area | 25% (1) | 55% (6) | 77% (10) | 62.5% (5) |
Pleural effusion | 25% (1) | 9% (1) | 15% (2) | 12.5% (1) |
Pericardial effusion | 0 | 9% (1) | 8% (1) | 12.5% (1) |
Deep vein thrombosis | 50% (2) | 46% (5) | 46% (6) | 62.5% (5) |
Data are presented as percentages (number of cases)